Feds Can't Dodge Gilead HIV Patent Counterclaims
By Lauren Berg · January 28, 2021, 10:14 PM EST
A Delaware federal judge Thursday denied the federal government's bid to toss Gilead Sciences' counterclaims in a case accusing the biotech company of infringing four government-owned patents for an HIV treatment....
To view the full article, register now.